Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor-1 (HIF-1) is a transcriptional complex that controls cellular and systemic homeostatic responses to oxygen availability. HIF-1 alpha is the oxygen-regulated subunit of HIF-1, an alpha beta heterodimeric complex. HIF-1 alpha is stable in hypoxia, but in the presence of oxygen it is targeted for proteasomal degradation by the ubiquitination complex pVHL, the protein of the von Hippel Lindau (VHL) tumour suppressor gene and a component of an E3 ubiquitin ligase complex. Capture of HIF-1 alpha by pVHL is regulated by hydroxylation of specific prolyl residues in two functionally independent regions of HIF-1 alpha. The crystal structure of a hydroxylated HIF-1 alpha peptide bound to VCB (pVHL, elongins C and B) and solution binding assays reveal a single, conserved hydroxyproline-binding pocket in pVHL. Optimized hydrogen bonding to the buried hydroxyprolyl group confers precise discrimination between hydroxylated and unmodified prolyl residues. This mechanism provides a new focus for development of therapeutic agents to modulate cellular responses to hypoxia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under normoxia, PHDs hydroxylate conserved proline residues within HIF-α subunits, increasing their affinity for the von Hippel–Lindau (pVHL) E3 ubiquitin ligase complex, which promotes polyubiquitination and 26S proteasomal degradation”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [44]
In the citing paper
“The subsequent discovery of a peptide from hypoxia-inducible factor 1 subunit-α (HIF1α) that bound the E3 ligase von Hippel–Lindau tumour suppressor (VHL)18,19 led to the design of cell-penetrating PROTACs that degraded a range of POIs.”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [18]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648 · cited 1×
“Cycles of rebuilding and refinement were carried out using the programs”
MethodHershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationAQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Research works printed but not linked: 1
- Hubbard, S. J. & Thornton, J. M. ‘NACCESS’, Computer Program Version 2.1.1 (Department of Biochemistry and Molecular Biology, Univ. Coll. London, London, 1996)
Cited by
Items 401–500 of 770
Strauss, E., Waliszewski, K., Oszkinis, G., & Staniszewski, R. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.02.007 · Cited by 28
Lei, Y., Hu, T., Wu, X., Wu, Y., Bao, Q., Zhang, L., Xia, H., Sun, H., You, Q., & Zhang, X. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00394 · Cited by 28
PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas
Mancarella, C., Morrione, A., & Scotlandi, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216346 · Cited by 29
Feng, Y., Hu, X., & Wang, X. (2024) · Biomarker Research · doi:10.1186/s40364-024-00638-1 · Cited by 30
Strategy and Design of In Situ Activated Protein Hydrolysis Targeted Chimeras
Lv, M.-Y., Hou, D., Liu, S., Cheng, D., & Wang, H. (2024) · ACS Nano · doi:10.1021/acsnano.4c11903 · Cited by 31
Rational design of a photo-crosslinking BODIPY for in situ protein labeling
Murale, D. P., Hong, S. C., Yun, J., Yoon, C. N., & Lee, J. (2015) · Chemical Communications · doi:10.1039/c5cc01068c · Cited by 32
Okumura, F., Uematsu, K., Byrne, S. D., Hirano, M., Akiko, J.-O., Nishikimi, A., Shuin, T., Fukui, Y., Nakatsukasa, K., & Kamura, T. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00067-16 · Cited by 29
Zhang, X., Lei, Y., Hu, T., Wu, Y., Li, Z., Jiang, Z., Yang, C., Zhang, L., & You, Q. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01161 · Cited by 27
Muddassir, M., Soni, K. V., Sangani, C. B., AlArifi, A. S., Afzal, M. F., Abduh, N. A. Y., Duan, Y., & Bhadja, P. (2020) · RSC Advances · doi:10.1039/d0ra07971e · Cited by 29
Regulation of the HIF switch in human endothelial and cancer cells
Slawski, J., Jaśkiewicz, M., Barton, A., Kozioł, S., Collawn, J. F., & Bartoszewski, R. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151386 · Cited by 26
Lin, J., Chen, Z., Zhang, D., Zhang, N., Chen, H., & Guo, D. (2025) · Macromolecular Rapid Communications · doi:10.1002/marc.202401051 · Cited by 31
Medicinal Chemistry of Inhibiting RING-Type E3 Ubiquitin Ligases
Blaquière, N., Villemure, E., & Staben, S. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01451 · Cited by 26
Li, X., Hattori, A., Takahashi, S., Gotö, Y., Harada, H., & Kakeya, H. (2019) · Cancer Science · doi:10.1111/cas.14236 · Cited by 27
Discoveries of how cells sense oxygen win the 2019 Nobel Prize in Physiology or medicine
Lee, C., Wu, C., & Yang, H. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.05.019 · Cited by 32
“Hydroxylation of specific proline residues in the ODD region of HIF-1a increases the affinity of HIF-1a for pVHL by at least three orders of magnitude [23].”
BackgroundThe pVHL neglected functions, a tale of hypoxia-dependent and -independent regulations in cancer
Minervini, G., Pennuto, M., & Tosatto, S. C. E. (2020) · Open Biology · doi:10.1098/rsob.200109 · Cited by 29
“Hypoxic conditions inhibit PHD activity allowingHIF-1α to escape proteolysis and translocate to the nucleus, where it promotes transcription of many genes involved in angiogenesis, glucose metabolism, cell survival and tumour progression [3,23].”
BackgroundHemati, M., Yousefi, B., Bahar, A., & Eslami, M. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00587-0 · Cited by 25
NADH elevation during chronic hypoxia leads to VHL-mediated HIF-1α degradation via SIRT1 inhibition
Joo, H.-Y., Jung, J. K., Kim, M., Woo, S. R., Jeong, J. M., Park, E., Kim, Y., Park, J., Kim, J., Yun, M., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01130-3 · Cited by 28
Erythropoiesis-Stimulating Agents
Elliott, S. (2010) · Cancer treatment and research · doi:10.1007/978-1-4419-7073-2_4 · Cited by 24
Hurst, J. H. (2016) · Journal of Clinical Investigation · doi:10.1172/jci90055 · Cited by 32
Adding structural information to the von Hippel–Lindau (VHL) tumor suppressor interaction network
Leonardi, E., Murgia, A., & Tosatto, S. C. E. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.070 · Cited by 28
Domukhovska, A., Burakgazi, Z. A., Springer, M., Nafchi, B., Beary, M. C., Acquisto, A., Acquisto, J., Komarov, V., Jensen, M., Gulledge, B., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115101 · Cited by 28
Lippl, K., Boleininger, A., McDonough, M. A., Abboud, M. I., Tarhonskaya, H., Chowdhury, R., Loenarz, C., & Schofield, C. J. (2018) · Hypoxia · doi:10.2147/hp.s174655 · Cited by 26
Self-citationStructure driven compound optimization in targeted protein degradation
Leissing, T. M., Luh, L. M., & Cromm, P. M. (2020) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2020.11.005 · Cited by 24
pVHL-mediated SMAD3 degradation suppresses TGF-β signaling
Zhou, J., Dabiri, Y., Gama-Brambila, R. A., Ghafoory, S., Altinbay, M., Mehrabi, A., Golriz, M., Blagojevic, B., Reuter, S., Han, K., et al. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202012097 · Cited by 24
Ogura, M., Shibata, T., Yi, J., Liu, J., Qu, R., Harada, H., & Hiraoka, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00044.x · Cited by 26
Marcsisin, S. R., & Engen, J. R. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.08.026 · Cited by 22
Manda, S., Lee, N. K., Oh, D., & Lee, J. (2020) · Molecules · doi:10.3390/molecules25081948 · Cited by 23
Hu, Z., Li, H., Wang, X., Ullah, K., & Xu, G. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103996 · Cited by 25
van der Wel, H., Johnson, J. M., Xu, Y., Karunaratne, C. V., Wilson, K. D., Vohra, Y., Boons, G., Taylor, C. M., Bendiak, B. K., & West, C. M. (2011) · Biochemistry · doi:10.1021/bi101977w · Cited by 23
Okadaic acid promotes angiogenesis via activation of hypoxia-inducible factor-1
Kim, Y., Ahn, K.-H., Kim, S.-Y., & Jeong, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.034 · Cited by 22
Thioamide substitution to probe the hydroxyproline recognition of VHL ligands
Soares, P., Lucas, X., & Ciulli, A. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.03.034 · Cited by 23
Tarade, D., Lee, J. E., & Ohh, M. (2019) · Nature Communications · doi:10.1038/s41467-019-11149-1 · Cited by 23
Inhibition of Mxi1 suppresses HIF-2α-dependent renal cancer tumorigenesis
Tsao, C. C., Teh, B. T., Jonasch, E., Schreiber‐Agus, N., Efstathiou, E., Hoang, A. G., Czerniak, P. B., Logothetis, C. J., & Corn, P. G. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.10.6583 · Cited by 23
von Hippel-Lindau disease: recent advances and therapeutic perspectives
Richard, S. (2003) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.3.2.215 · Cited by 26
Yokoe, S., & Asahi, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112232 · Cited by 23
“As shown in Figure 1a,b, HIF-1α was degraded in heart tissues from both transgenic mice, indicative of the upregulation of hydroxylation needed for HIF-1α degradation.”
BackgroundInfluentialLight-Activating PROTACs in Cancer: Chemical Design, Challenges, and Applications
Negi, A., Kesari, K. K., & Voisin‐Chiret, A. S. (2022) · Applied Sciences · doi:10.3390/app12199674 · Cited by 22
Review: Targeted therapy in renal cancer
Dorff, T. B., Goldkorn, A., & Quinn, D. I. (2009) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834009349119 · Cited by 22
Phospholipase D1 protein coordinates dynamic assembly of HIF-1α-PHD-VHL to regulate HIF-1α stability
Park, M. H., Choi, K., Jung, Y., & Min, D. S. (2014) · Oncotarget · doi:10.18632/oncotarget.2613 · Cited by 21
Vullo, D., Supuran, C. T., Scozzafava, A., Simone, G. D., Monti, S. M., Alterio, V., & Carta, F. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.06.005 · Cited by 21
Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs)
Tomaselli, D., Mautone, N., Mai, A., & Rotili, D. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112750 · Cited by 21
Wang, G., Song, H., Liu, S., Li, C., Geng, Y., & Gu, Z. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s65353 · Cited by 24
“21,22 Under normoxic conditions, HIF-1 α will be hydroxylated at two proline residues (Pro402 and Pro564) by prolyl-4-hydroxylase (PHD) and then recognized by von Hippel-Lindau (VHL) protein, the recognition component of an E3 ubiquitin ligase complex, leading to ubiquitination and rapid…”
Pinch, B. J., Buckley, D. L., Gleim, S., Brittain, S. M., Tandeske, L., D'Alessandro, P. L., Hauseman, Z. J., Lipps, J., Xu, L., Harvey, E. P., et al. (2022) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.08.007 · Cited by 20
Shmueli, M. D., Levy-Kanfo, L., Haj, E., Schoenfeld, A. R., Gazit, E., & Segal, D. (2018) · Oncogene · doi:10.1038/s41388-018-0491-x · Cited by 23
Lin, W., Li, Y., Yang, L., & Chen, T. (2020) · ACS Omega · doi:10.1021/acsomega.0c05221 · Cited by 20
Xue, X., Kang, J.-B., Yang, X., Li, N., Chang, L., Ji, J., Meng, X., Zhang, H., Zhong, Y., Yu, S., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113871 · Cited by 22
Jiang, Y., Ni, S., Xiao, B., & Jia, L. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.019 · Cited by 23
“Previous studies have reported that residue hydroxy proline 564 (Hyp564) of HIF-1 a is essential to bind VHL, thereby targeting Hyp of HIF-1 a regulating its ubiquitin-mediated proteasomal degradation 295,296 .”
BackgroundEffects of point mutations in pVHL on the binding of HIF‐1α
Domene, C., & Illingworth, C. J. R. (2011) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.23230 · Cited by 21
Davies, R., Moyes, C. D., & Wang, Y. S. (2011) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2011.01.012 · Cited by 27
DCNL1 Functions as a Substrate Sensor and Activator of Cullin 2-RING Ligase
Heir, P., Sufan, R. I., Greer, S. N., Poon, B., Lee, J. E., & Ohh, M. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01342-12 · Cited by 24
Gadd, M. S., Bulatov, E., & Ciulli, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131218 · Cited by 20
“For the pVHL:EloC:EloB complex the hinging motion of the substrate-binding domain ranges with motion at one end for the pVHL:EloC:EloB:HIF-1α complex [36–37], then the four protomers of the pVHL:EloC:EloB apo complex [38] and at the other extreme the pVHL: EloC:EloB:Cul2 structure [39].”
BackgroundExploring the Ubiquitin-Proteasome System (UPS) through PROTAC Technology
Cecchini, C., Tardy, S., Ceserani, V., Theurillat, J.-P. P., & Scapozza, L. (2020) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2020.274 · Cited by 20
Prolyl 4 Hydroxylase: A Critical Target in the Pathophysiology of Diseases
Kant, R., Bali, A., Singh, N., & Jaggi, A. S. (2013) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2013.17.2.111 · Cited by 22
Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors
Liu, L., Yu, J., Liu, Y., Xie, L., Hu, F., & Liu, H. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1572909 · Cited by 54
Role of the HBx oncoprotein in carbonic anhydrase 9 induction
Holotnakova, T., Tylková, L., Takáčová, M., Kopáček, J., Petrík, J., Pastoreková, S., & Pastorek, J. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21671 · Cited by 18
“Von Hippel Lindau protein (pVHL) recognizes the prolyl hydroxylated form of HIF-1a and recruits ubiquitin ligase for its ubiquitination [Hon et al., 2002].”
BackgroundA Genetically Encoded FRET Sensor for Hypoxia and Prolyl Hydroxylases
Youssef, S., Ren, W., & Ai, H. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00330 · Cited by 20
Depoix, C. L., de Selliers, I., Hubinont, C., & Debiève, F. (2017) · Molecular Human Reproduction · doi:10.1093/molehr/gax002 · Cited by 24
DeLigio, J. T., Lin, G., Chalfant, C. E., & Park, M. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.810127 · Cited by 24
Aurora A and AKT Kinase Signaling Associated with Primary Cilia
Nishimura, Y., Yamakawa, D., Shiromizu, T., & Inagaki, M. (2021) · Cells · doi:10.3390/cells10123602 · Cited by 20
Fiorillo, A., Morea, V., Colotti, G., & Ilari, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121309 · Cited by 20
Negi, A., Kesari, K. K., & Voisin‐Chiret, A. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112523 · Cited by 19
Pavliša, G., Vrbanić, V., Kuŝec, V., & Jaksic, B. S. (2004) · Clinical Science · doi:10.1042/cs20030165 · Cited by 17
Chen, S.-M., Li, Y., Wang, D., Zhang, G., & Chun-jiang, T. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.073 · Cited by 19
Hypoxic preconditioning protects against ischemic brain injury
Sharp, F. R., Ran, R., Lu, A., Tang, Y., Strauss, K. I., Glass, T. F., Ardizzone, T. D., & Bernaudin, M. (2004) · Neurotherapeutics · doi:10.1007/bf03206565 · Cited by 45
Ion channel regulation by chronic hypoxia in models of acute oxygen sensing
Peers, C., & Kemp, P. J. (2004) · Cell Calcium · doi:10.1016/j.ceca.2004.02.005 · Cited by 21
Corner, T. P., Teo, R. Z. R., Wu, Y., Salah, E., Nakashima, Y., Fiorini, G., Tumber, A., Brasnett, A., Holt‐Martyn, J. P., Figg, W. D., et al. (2023) · Chemical Science · doi:10.1039/d3sc04253g · Cited by 19
Self-citationQiu, Y., Wiewiora, R., Izaguirre, J. A., Xu, H., Sherman, W., Tang, W., & Huang, X. (2024) · JACS Au · doi:10.1021/jacsau.4c00503 · Cited by 20
DRG2 supports the growth of primary tumors and metastases of melanoma by enhancing VEGF‐A expression
Yoon, N. A., Jung, S. J., Choi, S. H., Ryu, J. H., Mani, M., Lee, U. H., Vo, M., Jeon, D. Y., Chung, S. W., Lee, B. J., et al. (2019) · FEBS Journal · doi:10.1111/febs.15125 · Cited by 17
Functional significance of germline EPAS1 variants
Dwight, T., Kim, E., Bastard, K., Benn, D. E., Eisenhofer, G., Richter, S., Mannelli, M., Rapizzi, E., Prejbisz, A., Pęczkowska, M., et al. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0280 · Cited by 15
Effect of conjugated linoleic acid on inhibition of prolyl hydroxylase 1 in hearts of mice
Zhang, J., & Li, D. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-22 · Cited by 17
Li, J., Liu, B., Zhang, X., Cao, D., & Chen, G. (2017) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.7b09068 · Cited by 17
Jeong, J., Cho, H., Moon, Y., Shim, N., Kim, J., Kim, J., Choi, S.-C., Park, J. Y., Kim, Y., & Kim, K. (2025) · Advanced Materials · doi:10.1002/adma.202516974 · Cited by 21
Wang, Z., Liu, J., Qiu, X., Zhang, D., Inuzuka, H., Chen, L., Chen, H., Xie, L., Kanıskan, H. Ü., Chen, X., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c06023 · Cited by 17
Potency-Enhanced Peptidomimetic VHL Ligands with Improved Oral Bioavailability
Wu, H., Murray, J. M., Ishisoko, N., Frommlet, A., Deshmukh, G. S., DiPasquale, A. G., Mulvihill, M. M., Zhang, D., Quinn, J. G., Blake, R. A., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02203 · Cited by 16
Frost, J., Ciulli, A., & Rocha, S. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15044.1 · Cited by 17
“Hydroxylated prolines on HIF-α create a recognition site with a substantial increase in affinity over the parent protein containing unmodified proline, for the E3 ubiquitin ligase, von Hippel–Lindau (VHL) tumour suppressor that poly-ubiquitinates HIF-α, targeting the protein for proteasomal degradation (Hon et al., 20…”
BackgroundDevelopment of the 99mTc-Hydroxamamide Complex as a Probe Targeting Carbonic Anhydrase IX
Iikuni, S., Tanimura, K., Watanabe, H., Shimizu, Y., Saji, H., & Ono, M. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01120 · Cited by 16
Rao, H., Li, X., Liu, M., Liu, J., Li, X., Xu, J., Li, L., & Gao, W. (2020) · Oncogene · doi:10.1038/s41388-020-1247-y · Cited by 15
A Bio-inspired Hypoxia Sensor using HIF1a-Oxygen-Dependent Degradation Domain
Iglesias, P., Penas, C., Barral-Cagiao, L., Pazos, E., & Costoya, J. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-43618-4 · Cited by 17
Quantitative analyses for effects of neddylation on CRL2VHL substrate ubiquitination and degradation
Wang, K., Reichermeier, K. M., & Liu, X. (2021) · Protein Science · doi:10.1002/pro.4176 · Cited by 15
Illingworth, C. J. R., Loenarz, C., Schofield, C. J., & Domene, C. (2010) · Biochemistry · doi:10.1021/bi100358t · Cited by 20
Self-citationLewis, M. D., & Roberts, B. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207384 · Cited by 21
“Oncogene The structural significance of the C-terminus of VHL and its relationship to function is unknown, other than the mutations in it that give rise to VHL disease.”
BackgroundInfluentialMcDermott, A., & Tavassoli, A. (2024) · Transcription · doi:10.1080/21541264.2024.2417475 · Cited by 20
“Hydroxylation of the proline residues is imperative for recruiting the von Hippel Lindau (VHL) protein, where the 4-hydroxypro-line establishes a highly specific interaction with a surface pocket on VHL [54,55].”
Exosomes in hypoxia: generation, secretion, and physiological roles in cancer progression
Mu, Y., Yang, M., Liu, J., Yao, Y., Sun, H., & Zhuang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1537313 · Cited by 23
Expression and purification of catalytically active human PHD3 in Escherichia coli
Fedulova, N., Hanrieder, J., Bergquist, J., & Emrén, L. O. (2007) · Protein Expression and Purification · doi:10.1016/j.pep.2007.02.018 · Cited by 16
Chen, L., Deng, Z., Xiong, Y., Liu, J., Huang, D., Wang, J., Chen, Y., Inuzuka, H., Xie, L., Chen, X., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c06306 · Cited by 18
Figg, W. D., Fiorini, G., Chowdhury, R., Nakashima, Y., Tumber, A., McDonough, M. A., & Schofield, C. J. (2023) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26541 · Cited by 15
Self-citationGenetically Encoded Biosensors for the Fluorescence Detection of O2 and Reactive O2 Species
Marchetti, M., Ronda, L., Cozzi, M., Bettati, S., & Bruno, S. (2023) · Sensors · doi:10.3390/s23208517 · Cited by 17
Chen, Y., Whitefield, B., Nevius, E., Hill, M., DelRosario, J., Sinitsyna, N., Shanmugasundaram, V., Mukherjee, D., Shi, L., Mayne, C. G., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01137 · Cited by 13
Genetics, Pathophysiology, and Current Challenges in Von Hippel–Lindau Disease Therapeutics
Gómez-Virgilio, L., Velazquez-Paniagua, M., Cuazozon-Ferrer, L., Silva-Lucero, M.-D.-C., Gutierrez-Malacara, A.-I., Padilla-Mendoza, J.-R., Borbolla-Vázquez, J., Díaz-Hernández, J.-A., Jiménez-Orozco, F.-A., & Cardenas-Aguayo, M.-D.-C. (2024) · Diagnostics · doi:10.3390/diagnostics14171909 · Cited by 18
“, the regulation of mTORC1 involves the protein regulated in”
BackgroundNiedermolekulare Inhibitoren der Wechselwirkung zwischen der E3‐Ligase VHL und HIF1α
Buckley, D. L., Gustafson, J. L., Molle, I. V., Roth, A. G., Tae, H. S., Gareiss, P. C., Jorgensen, W. L., Ciulli, A., & Crews, C. M. (2012) · Angewandte Chemie · doi:10.1002/ange.201206231 · Cited by 14
Chemical Methods to Knock Down the Amyloid Proteins
Gao, N., Chen, Y., Zhao, Y., & Li, Y. (2017) · Molecules · doi:10.3390/molecules22060916 · Cited by 14
Targeting Cullin-RING Ubiquitin Ligases and the Applications in PROTACs
Gong, L., Cui, D., Xiong, X., & Zhao, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_19 · Cited by 15
Macrophage Migration Inhibitory Factor Manipulation and Evaluation in Tumoral Hypoxic Adaptation
Winner, M. G., Leng, L., Zundel, W., & Mitchell, R. A. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35018-0 · Cited by 14
“Hydroxylation allows recognition of HIF-1α by the von Hippel-Lindau tumor suppressor protein (pVHL), which serves as the recognition component of the E3 ubiquitin ligase complex consisting of VHL/elongin C/elongin B (VCB), cullin 2, and the RING-H2 finger protein Rbx-1 (Hon et al., 2002).”
BackgroundPrecise Identification of Native Peptides with Posttranslational Proline Hydroxylation by Nanopore
Chang, J.-W., Gao, Y., Zou, A., Li, M., Long, Y., & Jiang, J. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202422692 · Cited by 16
Mareczek, L., Mueller, L. K., Halstenberg, L., Geiger, T. M., Walz, M., Zheng, M. J., & Hausch, F. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070924 · Cited by 16
PROTAR Vaccine 2.0 generates influenza vaccines by degrading multiple viral proteins
Zhang, C., Hou, J., Li, Z., Shen, Q., Bai, H., Chen, L., Shen, J., Wang, P., Su, Y., Li, J., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-024-01813-z · Cited by 22
“In that design, the peptide, ALAPYIP, mediates the recognition of M1 protein by the von Hippel–Lindau (VHL) E3 ubiquitin ligase 8–10 and subsequent proteasomal degradation.”
Evidence for a Stereoelectronic Effect in Human Oxygen Sensing
Loenarz, C., Mecinović, J., Chowdhury, R., McNeill, L. A., Flashman, E., & Schofield, C. J. (2009) · Angewandte Chemie · doi:10.1002/ange.200805427 · Cited by 14
Self-citationMesa‐Ciller, C., Turiel, G., Guajardo-Grence, A., López-Rodríguez, A. B., Egea, J., Bock, K. D., Aragonés, J., & Urrutia, A. A. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221118236 · Cited by 13
Response to Sorafenib in a Patient with Metastatic Xp11 Translocation Renal Cell Carcinoma
Hou, M., Hsieh, J., Chang, N.-J., Huang, H., Wang, H., Chuang, C., Hsu, T., & Chang, J. W. (2010) · Clinical Drug Investigation · doi:10.2165/11537220-000000000-00000 · Cited by 13
Soler-Torronteras, R., Lara‐Chica, M., García, V., Calzado, M. A., & Muñóz, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.07.005 · Cited by 13
Yokoe, S., Nakagawa, T., Kojima, Y., Higuchi, K., & Asahi, M. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.014 · Cited by 22
Metadata
- Authors
- Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Jones, E. Yvonne
- ORCID
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6892
- Pages
- 975-978
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2167786713
- Cited by
- 751
- References
- 31
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 46 · 2023: 43 · 2022: 37 · 2021: 35 · 2020: 43 · 2019: 19 · 2018: 24 · 2017: 23 · 2016: 28 · 2015: 24 · 2014: 20 · 2013: 23 · 2012: 26
- FWCI
- 17.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIF-1α, von Hippel-Lindau protein, E3 ubiquitin ligase, hypoxia, oxygen sensing, protein-protein binding, crystal structure, hydrogen bonding, ubiquitination, proteasomal degradation, transcriptional regulation
- MeSH terms
- Elongin, Amino Acid Sequence, Hypoxia, Binding Sites, Humans, Hydrogen Bonding, Hydroxylation, Hydroxyproline, Kinetics, Ligases, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Structure-Activity Relationship, Substrate Specificity, Transcription Factors, Sequence Alignment, Crystallography, X-Ray, Surface Plasmon Resonance, Amino Acid Motifs, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.